Breast‐conserving therapy (BCT) for early‐stage breast cancer

Abstract

Several patient and tumor factors go into the decision process to determine whether a breast cancer patient is a good candidate for breast‐conserving therapy. The patient must be seen by all disciplines before any therapeutic intervention. When used appropriately, breast‐conserving therapy produces maximal disease control and improves quality of life in patients with early‐stage breast cancer. J. Surg. Oncol. 2004;85:14–27.